Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial

The Lancet

Volumn 345, Issue 8963, 1995, Pages 1455-1463

  The Eclampsia Trial Collaborative Group, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM; MAGNESIUM SULFATE; PHENYTOIN;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DRUG CHOICE; ECLAMPSIA; FEMALE; HUMAN; INTENSIVE CARE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MULTICENTER STUDY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; RESPIRATORY TRACT INTUBATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029004929     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91034-4     Document Type: Article

References (36)

1. Eclampsia in the United Kingdom
2. Geographic variation in the incidence of hypertension in pregnancy
3. Eclampsia at Harare Maternity Hospital. An epidemiological study
4. Seasonal incidence of eclampsia and its relationship to meteorological data in Mozambique
5. The safe motherhood initiative: a call to action
6. Maternal mortality—a neglected tragedy. Where is the M in MCH?
7. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean
8. The case against magnesium sulfate for eclamptic convulsions
9. Management of severe pre-eclampsia and eclampsia by UK consultants
10. Management of pre-eclampsia
11. An analysis of 575 cases of eclamptic and pre-eclamptic toxemias treated by intravenous injections of magnesium sulphate
12. Problems encountered in the treatment of pregnancy-induced hypertension. A point of view
13. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases
14. The case for magnesium sulfate in preeclampsia-eclampsia
15. Phenytoin sodium and magnesium sulphate in the management of eclampsia
16. A safer and more effective treatment regimen for eclampsia
17. Effect of magnesium sulfate on brain blood flow in preeclampsia: a randomised placebo-controlled study
18. Action of magnesium sulfate in the treatment of preeclampsia-eclampsia
19. Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure
20. Use of benzodiazepines in the management of eclampsia
21. Eclampsia in Enugu, Eastern Nigeria
22. Phenytoin infusion in severe pre-eclampsia
23. Single high dose of intravenous phenytoin sodium for the treatment of eclampsia
24. Magnesium sulphate versus diazepam in the management of eclampsia: a randomised controlled trial
25. Phenytoin versus magnesium sulfate in preeclampsia: a pilot study.
26. Magnesium sulfate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension
27. Clinical experience with phenytoin prophylaxis in severe preeclampsia
28. Maternal-perinatal outcome in 254 consecutive cases
29. Phenytoin prophylaxis in severe pre-eclampsia and eclampsia
30. Magnesium sulphate for pre-eclampsia and eclampsia: the evidence so far
31. A continuing controversy: magnesium sulfate in the treatment of eclamptic seizures